Abstract
Developing efficient micro-/nano-enabled sensing platforms based on the 5th and 6th generation is an escalating field where the data can be collected, transferred, and analyzed using AI and IoT systems in point-of-care (POC) situations. For personalized health, detecting low-concentration biomarkers requires highly efficient sensing electrodes. Interdigitated electrodes (IDEs)-based biosensors show promise due to their integration with microelectronics and ability for health monitoring. Systematic exploration of innovative designs, fabrication techniques, and surface chemistry is key to overcoming challenges and enabling efficient biosensing. This article explores IDEs’ potential in the early detection of diseases like cancer, COVID-19, and diabetes and discusses future directions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
